HOME >> BIOLOGY >> NEWS
Evidence builds for potential new cancer drug target

In a paper published today in the Proceedings of the National Academy of Sciences, Temple University researchers report that one of the functions of the c-myb gene, which leukemia cells depend on for proliferation, is the formation of white blood cells.

"This study is another step in the process of validating the c-myb gene as a potential target for new cancer drugs," said Prem Reddy, Ph.D., professor and director of the Fels Institute for Cancer Research and Molecular Biology at Temple University School of Medicine.

Knowing that the c-myb gene played a role in the spread of leukemia, the researchers wanted to determine the gene's normal function. This was accomplished by deleting the c-myb gene in a mouse model. New technology allowed the scientists to delete c-myb from one specific type of tissue in the model rather than from the entire organism.

"We removed the c-myb gene from T cells and in the process discovered that c-myb is required for white blood cell formation," said Reddy. In other research conducted by the team but not yet published, c-myb was deleted from breast tissue.

The researchers believe that this gene plays a critical role in breast cancer and want to show the effects of its deletion on breast tumor cell proliferation.

The group's research is providing detailed genetic explanations of how and why c-myb is essential for the proliferation of white blood cells and breast cells by demonstrating that when it's removed, cell proliferation is impaired and the risk of developing cancer is reduced.

"We hope to develop a drug that blocks the harmful activity of this gene in the near future. This finding was very serendipitous. We used to think c-myb was only associated with the development of leukemia but found that it's also involved in the development of breast cancer," said Reddy.

Other researchers on the team include the study's first author, Yen K. Lieu, Atul Kumar, Anthony G. Pajerowski, and Thomas J. Rog
'"/>

Contact: Eryn Jelesiewicz
dobeck@temple.edu
215-707-0730
Temple University
27-Sep-2004


Page: 1 2

Related biology news :

1. Evidence for sympatric speciation by host shift in the sea
2. Evidence for the impact of climate change on deep-sea biodiversity
3. Evidence for fat hormone target in brain
4. Evidence of nanobacterial-like structures found in human calcified arteries and cardiac valves
5. Evidence shows the heart has stem cells able to regenerate muscle tissue lost to disease, wear
6. Evidence for orangutan culture
7. Evidence suggests that standard smallpox vaccine offers long-term immunity
8. Evidence that adults stem cells differentiate like embryonic stem cells published in Nature
9. When Shewanella meets goethite: Evidence found of recognition between animate and inanimate objects
10. Evidence links protein damage to Parkinsons
11. Evidence suggests food preservatives may help prevent cavities

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/31/2020)... (PRWEB) , ... July 30, 2020 , ... ... Research (SBIR) Phase II contract awarded by the Joint Science & Technology Office—Chemical ... this project is to develop, optimize, and scale-up a highly efficient mammalian cell ...
(Date:7/18/2020)... ... 2020 , ... A study has been published in the ... noise control device to attenuate typical noises in a simulated neonatal intensive care ... sounds from patient monitors, ventilators and other bedside devices that would affect the ...
(Date:7/10/2020)... ... ... Today CJ BIO announced the first in a series of Food Ingredient MasterClass ... is revolutionizing ingredient mixes, nutritional content and flavor profiles across a range of savory ... at11:00 AM (CDT) during SHIFT20, the virtual edition of the IFT Annual Meeting & ...
Breaking Biology News(10 mins):
(Date:7/22/2020)... ... July 22, 2020 , ... Join experts from Reed Tech , ... Solutions, in a one hour live webinar on Thursday, August 13, 2020 ... for drugs and medical devices. Specifically, for medical devices, the NMPA has departments dealing ...
(Date:7/18/2020)... ... July 16, 2020 , ... “We are thrilled to ... Bioactives. “It’s the only technology of its kind on the market and we were ... with the protective capacity of traditional cultured ingredients, creating a natural way to extend ...
(Date:7/18/2020)... ... , ... dicentra , a leading Contract Research Organization ... pleased to announce that Charles Galea has joined its clinical trials division as ... accomplished and results-driven sales executive with over 10 years of expertise in business ...
(Date:7/10/2020)... (PRWEB) , ... July 09, ... ... biotechnology company, announced today that Massachusetts Institute of Technology (MIT) has expanded ... broader license allows PathSensors to move into the point-of-care diagnostic market, focusing ...
Breaking Biology Technology:
Cached News: